The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
Glob Cardiol Sci Pract
.
2017 Mar 31;2017(1):e201702.
doi: 10.21542/gcsp.2017.2.
Author
Nabil G Seidah
1
Affiliation
1
Laboratory of Biochemical Neuroendocrinology, IRCM; Affiliated to the University of Montreal, 110 Pine Avenue West, Montreal, QC, H2W 1R7Canada.
PMID:
28971102
PMCID:
PMC5621713
DOI:
10.21542/gcsp.2017.2
No abstract available
Publication types
Review